Home/Sutro Biopharma/Devendra Luhar
DL

Devendra Luhar

Senior Vice President, Technical Operations

Sutro Biopharma

Sutro Biopharma Pipeline

DrugIndicationPhase
Luveltamab tazevibulin (luvelta)Follicular Lymphoma (3L+)Phase 2/3
STRO-003Solid TumorsPreclinical
CC-99712 (BCMA ADC)Multiple MyelomaPhase 1
M1231 (EGFR/MUC1 bispecific ADC)Non-Small Cell Lung Cancer, Esophageal Squamous Cell CarcinomaPhase 1